On February 22, 2021 Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the following virtual investor conferences (Press release, Leap Therapeutics, FEB 22, 2021, View Source [SID1234575407]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Raymond James 42nd Annual Institutional Investors Conference
Date: Monday, March 1
Presentation Time: 10 a.m. Eastern Time

H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9 – Wednesday, March 10

The H.C. Wainwright presentation will be available on Tuesday, March 9, 2021 at 7:00 a.m. Eastern Time and may be accessed on the Investors page of the company’s website at View Source, and a live webcast of the Raymond James presentation can be accessed in the same section of the Company’s website. A replay of the events will also be available for a limited time.